Risk of venous thrombosis in patients with hepatic malignancies undergoing surgical resection

Indian Journal of Gastroenterology

Volumn 27, Issue 4, 2008, Pages 159-161

  Yates, Todd J ^a   Abouljoud, Marwan ^a   Lambing, Angela ^a   Kuriakose, Philip ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER RESEARCH; HUMAN; LIVER METASTASIS; LIVER TUMOR; MORBIDITY; RISK FACTOR; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK; VENOUS THROMBOSIS;

EID: 57349130963     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001;119:132S-175S.
2. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162:1245-8.
3. Khushal A, Quinlan D, Alikhan R, Gardner J, Bailey C, Cohen A. Thromboembolic disease in surgery for malignancy - rationale for prolonged thromboprophylaxis. Semin Thromb Hemost 2002;28:569-76.
4. Donati MB. Cancer and thrombosis. Hemostasis 1994;24:128-31.
5. Ambrus JL, Ambrus CM, Pickern J, Soldes S, Bross I. Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis. J Med 1975;6:433-58.
6. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
7. ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg 1997;84:1099-1103.
8. Flordal PA, Bergqvist D, Burmark U-S, Ljungstrom KG, Torngren S. Major thromboembolism and diffuse bleeding after elective general abdominal surgery-clinical risk factors. Thromb Hemost 1995;73:1096 [Abstract].
9. Kakkar AK, Williamson RC. Prevention of venous thromboembolism in cancer patients. Sem Thromb Hemost 1999;25:239-43.
10. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA 2005;293:715-22.
11. Francis JL, Biggerstaff J, Amirkhosravi A. Hemostasis and malignancy. Sem Thromb Hemost 1998;24:93-109.
12. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Hemost 2002;87:575-9.
13. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006;119:60-8.